World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
27064
World Ranking
13209
National Ranking
506

Overview

Harry C. Schouten is affiliated with Maastricht University in the Netherlands, focusing primarily on medicine with a specialization in hematology. Their research spans multiple subfields including hematology, genetics, oncology, physiology, and nutrition and dietetics.

The scientist's body of work covers a range of topics within medical research, with particular emphasis on acute myeloid leukemia and hematopoietic stem cell transplantation. Other recurring themes include nutrition and health in aging, clinical nutrition and gastroenterology, myeloproliferative neoplasms, and quality of life issues concerning childhood cancer survivors.

Frequent publication venues for Schouten include Clinical Nutrition ESPEN, UNC Libraries, Transplantation and Cellular Therapy, Bone Marrow Transplantation, and HemaSphere.

  • Clinical Nutrition ESPEN
  • UNC Libraries
  • Transplantation and Cellular Therapy
  • Bone Marrow Transplantation
  • HemaSphere

Their research collaborations frequently involve the following co-authors:

  • Lidwine W. Tick
  • Hillard M. Lazarus
  • Sandra Beijer
  • Mahmoud Aljurf
  • Baldeep Wirk

Notable recent publications by Harry C. Schouten include:

  • Fedratinib in patients with myelofibrosis previously treated with ruxolitinib: An updated analysis of the JAKARTA2 study using stringent criteria for ruxolitinib failure, 2020, American Journal of Hematology
  • Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research Study, 2020, Transplantation and Cellular Therapy
  • A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes, 2020, Biology of Blood and Marrow Transplantation
  • Fedratinib Improves Myelofibrosis-related Symptoms and Health-related Quality of Life in Patients with Myelofibrosis Previously Treated with Ruxolitinib: Patient-reported Outcomes from the Phase II JAKARTA2 Trial, 2021, HemaSphere
  • Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK-NUP214 shows a favourable outcome when performed in first complete remission, 2020, British Journal of Haematology

Best Publications

  • Prevalence of pain in patients with cancer: a systematic review of the past 40 years

    M.H.J. van den Beuken-van Everdingen;J.M. de Rijke;A.G. Kessels;H.C. Schouten

  • High-dose daunorubicin in older patients with acute myeloid leukemia.

    Bob Löwenberg;Gert J. Ossenkoppele;Wim van Putten;Harry C. Schouten

  • Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.

    G Socié;J V Stone;J R Wingard;D Weisdorf

  • Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

    Jan J. Cornelissen;Wim L. J. van Putten;Leo F. Verdonck;Matthias Theobald

  • High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial.

    Harry C. Schouten;Wendi Qian;Stein Kvaloy;Adolfo Porcellini

  • Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia.

    Bob Löwenberg;Wim van Putten;Matthias Theobald;Jurg Gmür

  • Cytarabine dose for acute myeloid leukemia.

    Bob Lowenberg;Thomas Pabst;Edo Vellenga;Wim van Putten

  • Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009.

    P. Ljungman;M. Bregni;M. Brune;J. Cornelissen

  • Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs

    Robyn M. Emanuel;Amylou C. Dueck;Holly L. Geyer;Jean Jacques Kiladjian

  • Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.

    Koen Van Besien;Fausto R. Loberiza;Ruta Bajorunaite;James O. Armitage

  • Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma

    L F Verdonck;W L van Putten;A Hagenbeek;H C Schouten

  • Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy.

    P Sonneveld;M de Ridder;H van der Lelie;K Nieuwenhuis

  • High prevalence of pain in patients with cancer in a large population-based study in The Netherlands.

    Marieke H.J. van den Beuken-van Everdingen;Janneke M. de Rijke;Alfons G. Kessels;Harry C. Schouten

  • OUTCOME OF TRANSPLANTATION FOR MYELOFIBROSIS

    Karen K. Ballen;Smriti Shrestha;Kathleen A. Sobocinski;Mei Jie Zhang

  • Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study

    Claire N. Harrison;Nicolaas Schaap;Alessandro M. Vannucchi;Jean Jacques Kiladjian

  • Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe

    A. Urbano-Ispizua;N. Schmitz;T.J.M. de Witte;F. Frassoni

  • Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States

    Lori Muffly;Marcelo C. Pasquini;Michael Martens;Ruta Brazauskas

  • Allogeneic Stem-Cell Transplantation As Salvage Therapy for Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Relapsing After an Autologous Stem-Cell Transplantation: An Analysis of the European Group for Blood and Marrow Transplantation Registry

    Roel J.W. Van Kampen;Carmen Canals;Harry C. Schouten;Arnon Nagler

  • Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma

    Sonali M. Smith;Linda J. Burns;Koen W. van Besien;Jennifer LeRademacher

  • Withdrawal from labour force due to work disability in patients with ankylosing spondylitis

    A Boonen;A Chorus;H Miedema;D van der Heijde

Frequent Co-Authors

Bipin N. Savani
Bipin N. Savani Vanderbilt University Medical Center
Hillard M. Lazarus
Hillard M. Lazarus Case Western Reserve University
Ruben A. Mesa
Ruben A. Mesa The University of Texas Health Science Center at San Antonio
Jan J. Cornelissen
Jan J. Cornelissen Erasmus University Rotterdam
Alessandro M. Vannucchi
Alessandro M. Vannucchi University of Florence
Francesco Passamonti
Francesco Passamonti University of Milan
Sonja Zweegman
Sonja Zweegman Amsterdam UMC
Claire N. Harrison
Claire N. Harrison Guy's and St Thomas' NHS Foundation Trust
Mahmoud Aljurf
Mahmoud Aljurf King Faisal Specialist Hospital & Research Centre

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are considering a career in medicine or seeking alternative pathways in healthcare, there are a variety of online degree programs that can help you get started or advance your career. Accelerated healthcare administration degrees offer a fast-track route into management roles, equipping graduates with leadership and organizational expertise needed in hospitals, clinics, and other healthcare settings.

For those with a nursing background, ASN to nurse practitioner programs provide flexible bridge options, allowing registered nurses to earn advanced qualifications and move into high-demand nurse practitioner positions. Those interested in preventative health and dietetics may benefit from pursuing an online degree in nutrition, which can open doors to opportunities in wellness, education, and clinical nutrition.

Additionally, students seeking to specialize in healthcare leadership should consider online MHA programs that are CAHME-accredited, which are highly regarded for quality and industry recognition. Each of these online degrees provides both the flexibility for working professionals and the credentials needed to expand your healthcare career options.

Best Scientists Citing Harry C. Schouten

Trending Scientists